Express Scripts President Adam Kautzner Appointed Chair of PCMA Board of Directors

(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) announced today that Adam Kautzner, PharmD, president of Express Scripts, has assumed the role of chairman of the PCMA Board of Directors.

“I would like to congratulate Adam for his appointment to this important leadership role,” said PCMA President and CEO JC Scott. “Adam’s experience and clinical expertise as pharmacist will be invaluable as pharmacy benefit companies continue working to secure savings, enable better health outcomes, expand access to quality coverage and lower prescription drug costs for patients.”

“As chairman, I look forward to working alongside PCMA’s Board of Directors and leadership team to advance pharmacy benefit companies’ vision for a more sustainable and affordable health care future,” added Kautzner. “Pharmacy benefit companies work every day to drive value for patients and leverage our clinical expertise to address our country’s biggest health care challenges and improve outcomes for the patients we serve.”

Kautzner has been with Express Scripts for over 15 years. Prior to being named president, he held various leadership roles overseeing supply chain strategy and initiatives, managing key strategic relationships, and directing formulary development. Most recently, he served as senior vice president of supply chain, responsible for pharmaceutical contracting, retail network contracting and drug sourcing. Previously, he was chief pharma trade relations officer where he led interactions and contracting with pharma, supply chain account management, and drug formularies.

Adam earned his doctorate of pharmacy from St. Louis College of Pharmacy and Authorized Nuclear Pharmacist certification from Purdue University.


PCMA is the national association representing America’s pharmacy benefit companies. Pharmacy benefit companies are working every day to secure savings, enable better health outcomes, and support access to quality prescription drug coverage for more than 275 million patients. Learn more at